Chronic Kidney Disease Trial, Recruiting NCT06051058 Sponsor: Brigham and Women's Hospital Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06051058
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 55 or older who have a primary care doctor at Brigham (or an appointment at one of 15 specific locations) and are being discharged from a Brigham and Women's Hospital general medicine unit
  • People being discharged to their own home, a home health care service, or an assisted living facility
  • People (or their designated healthcare decision-maker) who can speak English fluently
  • People who have at least one of the following conditions listed in their medical record — heart failure, type 2 diabetes, or chronic kidney disease — plus at least one other ongoing health condition also listed in their medical record

Who may not be able to join:

  • People aged 55 or older whose primary care doctor is based at the Westwood, Pembroke, or Transition Clinic locations and who were admitted to an ICU, or an obstetrics, surgical, cardiology, oncology, orthopaedics, or other specialist unit
  • People who are currently pregnant
  • People who are a prisoner, held in a detention facility, or in police custody
  • People whose discharge from hospital is planned within 3 hours of being assessed for the trial
  • People who are too unwell to take part, or who have active psychosis, serious mental illness, delirium, or severe dementia
  • People (and whose healthcare decision-maker) cannot speak English fluently
  • People who are not expected to be discharged to a home setting
  • People who do not have a device capable of running the trial's app (confirm with trial site)
  • People who do not have a working telephone available for a 30-day follow-up call

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lipika Samal, MD, MPH, Brigham and Women's Hospital

Phone: 617-732-7063

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 October 2024
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To determine the effect of the Care Transitions App on post-discharge adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov